UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Nobligan 100 mg/ml orala droppar, lösning
- Invented name part: Nobligan
- Strength part: 100 mg/ml
- Pharmaceutical dose form part: orala droppar, lösning
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Oral drops, solution
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 14305
Region: Kingdom of Sweden
Marketing authorisation holder: Grünenthal GmbH
Identifier:
Status: Valid (1998-11-20)
Package 1 of 1
PCID:
Description: Flaska, 96 ml (glas)
Marketing status:
Pack size:
Package: 1 Box (Cardboard)
Containing:
Package: 1 Bottle (Glass)
Containing: 96 millilitre(s)
Manufactured Item
Dose form: Oral drops, solution
Unit of presentation: Bottle
Ingredient
Role: Active
Substance: Tramadol hydrochloride
Concentration strength: 100 milligram(s) / 1 millilitre(s)
Reference strength: Tramadol 88 milligram(s) / 1 millilitre(s)
Administrable Product (1 of 1)
Dose form: Oral drops, solution
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: Tramadol hydrochloride
Concentration strength: 100 milligram(s) / 1 millilitre(s)
Reference strength: Tramadol 88 milligram(s) / 1 millilitre(s)